About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

B-294944.3 1 (2005-02-02)

handle is hein.gao/gaocrptaqtd0001 and id is 1 raw text is: 



SGAO

     Accountability* Integrity  Reliability





        Decision


        Matter of: Boehringer Ingelheim Pharmaceuticals, Inc.

        File:       B-294944.3; B-295430

        Date:       February 2, 2005

        John A. Burkholder, Esq., and Frank Rapoport, Esq., McKenna Long & Aldridge, for
        the protester.
        John S. Pachter, Esq., Jonathan D. Shaffer, Esq., and Sophia R. Zetterlund, Esq.,
        Smith Pachter McWhorter & Allen, for AstraZeneca Pharmaceuticals LP, an
        intervenor.
        Melbourne A. Noel, Jr., Esq., Phillipa L. Anderson, Esq., and Philip S. Kauffman, Esq.,
        Department of Veterans Affairs, for the agency.
        Ralph 0. White, Esq., and Christine S. Melody, Esq., Office of the General Counsel,
        GAO, participated in the preparation of the decision.
        DIGEST

        Protests arguing that solicitations for formulary drugs are unduly restrictive because
        the solicitations limit competition to those drugs within the class that treat certain
        conditions is denied where the limits on competition reasonably reflect the agency's
        needs.
        DECISION

        Boehringer Ingelheim Pharmaceuticals, Inc. (BI) protests the terms of two
        solicitations issued by the Department of Veterans Affairs (VA) for Angiotensin II
        Receptor Antagonists, also known as Angiotensin II Receptor Blockers (or ARBs),
        for inclusion on the VA's National Formulary.' One solicitation (request for



        A formulary is a list of prescription drugs, grouped by therapeutic class, which a
        health care organization prefers that its physicians prescribe. Drugs are chosen for a
        formulary on the basis of their medical value and price. The formulary system seeks
        to standardize drug use, ensure availability and consistency of the product for
        nationwide usage, increase the continuity of care, standardize the process for
        evaluating the safety and efficacy of drugs, and manage cost growth. Schering Cor.,
        B-286329.3, B-286329.4, Feb. 2, 2001, 2001 CPD   19 at 2 n.2; VA Health Care: VA's
                                                                         (continued...)

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most